Perfil
Jennifer Fitzpatrick is currently the Vice President & Corporate Counsel at SAGE Therapeutics, Inc. She previously worked as Secretary & Director at Aegerion Pharmaceuticals, Inc.
Cargos activos de Jennifer Fitzpatrick
| Empresas | Cargo | Inicio |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Jennifer Fitzpatrick.
| Empresas | Cargo | Fin |
|---|---|---|
| AEGERION PHARMACEUTICALS, INC. | Director/Board Member | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer Fitzpatrick
